{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:26:08Z","timestamp":1719015968843},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,21]]},"DOI":"10.7759\/cureus.62835","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T13:17:56Z","timestamp":1718975876000},"source":"Crossref","is-referenced-by-count":0,"title":["Excessive Dynamic Airway Collapse After Entecavir Use in a Patient With Pegylated Interferon-Induced Undifferentiated Connective Tissue Disease and Entecavir Use to Prevent Hepatitis B Virus Reactivation Upon Giving Rituximab"],"prefix":"10.7759","author":[{"given":"Muhammad Zain","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghias Un Nabi","family":"Tayab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Imran","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqra","family":"Seher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00393_3.x","article-title":"Consensus interferon induced interstitial pneumonitis in a patient with HCV","volume":"101","author":"Hillier AE","year":"2006","unstructured":"Hillier AE, Mand J, Raza A, Markov M, Nadir A. Consensus interferon induced interstitial pneumonitis in a patient with HCV. Am J Gastroenterol. 2006, 101:200-2. 10.1111\/j.1572-0241.2006.00393_3.x","journal-title":"Am J Gastroenterol"},{"key":"ref2","article-title":"[Clinical features of interstitial pneumonitis due to interferon alpha therapy for chronic hepatitis C]","volume":"29","author":"Ji FP","year":"2009","unstructured":"Ji FP, Li ZX, Deng H, Xue HA, Liu Y, Li M. [Clinical features of interstitial pneumonitis due to interferon alpha therapy for chronic hepatitis C]. Nan Fang Yi Ke Da Xue Xue Bao. 2009, 29:667-70.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1086\/425746","article-title":"Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature","volume":"39","author":"Midturi J","year":"2004","unstructured":"Midturi J, Sierra-Hoffman M, Hurley D, Winn R, Beissner R, Carpenter J. Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature. Clin Infect Dis. 2004, 39:1724-9. 10.1086\/425746","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4065\/74.4.367","article-title":"Severe exacerbation of asthma: a new side effect of interferon-alpha in patients with asthma and chronic hepatitis C","volume":"74","author":"Bini EJ","year":"1999","unstructured":"Bini EJ, Weinshel EH. Severe exacerbation of asthma: a new side effect of interferon-alpha in patients with asthma and chronic hepatitis C. Mayo Clin Proc. 1999, 74:367-70. 10.4065\/74.4.367","journal-title":"Mayo Clin Proc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.184870","article-title":"Tracheobronchomalacia\/excessive dynamic airway collapse in patients with chronic obstructive pulmonary disease with persistent expiratory wheeze: a pilot study","volume":"33","author":"Sindhwani G","year":"2016","unstructured":"Sindhwani G, Sodhi R, Saini M, Jethani V, Khanduri S, Singh B. Tracheobronchomalacia\/excessive dynamic airway collapse in patients with chronic obstructive pulmonary disease with persistent expiratory wheeze: a pilot study. Lung India. 2016, 33:381-4. 10.4103\/0970-2113.184870","journal-title":"Lung India"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/596857","article-title":"Excessive dynamic airway collapse: an unexpected contributor to respiratory failure in a surgical patient","volume":"2015","author":"Lyaker MR","year":"2015","unstructured":"Lyaker MR, Davila VR, Papadimos TJ. Excessive dynamic airway collapse: an unexpected contributor to respiratory failure in a surgical patient. Case Rep Anesthesiol. 2015, 2015:596857. 10.1155\/2015\/596857","journal-title":"Case Rep Anesthesiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2019.100827","article-title":"Upper airway wheezing: Inducible laryngeal obstruction vs. excessive dynamic airway collapse","volume":"27","author":"Rendo M","year":"2019","unstructured":"Rendo M, Sjulin TJ, Morris MJ, Burguete S. Upper airway wheezing: Inducible laryngeal obstruction vs. excessive dynamic airway collapse. Respir Med Case Rep. 2019, 27:100827. 10.1016\/j.rmcr.2019.100827","journal-title":"Respir Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4274\/vhd.2017.0016","article-title":"Assessment of quality of life of patients with chronic hepatitis B and C treated with pegylated interferon-alpha","volume":"24","author":"Alay H","year":"2018","unstructured":"Alay H, \u00d6zden K, Erol S, Celik N, Parlak E, Parlak M. Assessment of quality of life of patients with chronic hepatitis B and C treated with pegylated interferon-alpha. Viral Hepat J. 2018, 24:25-42. 10.4274\/vhd.2017.0016","journal-title":"Viral Hepat J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212203","article-title":"Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial","volume":"321","author":"Davis GL","year":"1989","unstructured":"Davis GL, Balart LA, Schiff ER, et al.. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med. 1989, 321:1501-6. 10.1056\/NEJM198911303212203","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200110000-00015","article-title":"Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection","volume":"322","author":"Karim A","year":"2001","unstructured":"Karim A, Ahmed S, Khan A, Steinberg H, Mattana J. Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection. Am J Med Sci. 2001, 322:233-5. 10.1097\/00000441-200110000-00015","journal-title":"Am J Med Sci"},{"key":"ref11","article-title":"Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review","author":"Shepherd J","year":"2000","unstructured":"Shepherd J, Waugh N, Hewitson P. Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review. Database of Abstracts of Reviews of Effects (DARE): Quality-Assessed Reviews. Centre for Reviews and Dissemination, York; 2000."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05999.x","article-title":"Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C","volume":"97","author":"Kumar KS","year":"2002","unstructured":"Kumar KS, Russo MW, Borczuk AC, et al.. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Am J Gastroenterol. 2002, 97:2432-40. 10.1111\/j.1572-0241.2002.05999.x","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.3.939","article-title":"Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C","volume":"105","author":"Chin K","year":"1994","unstructured":"Chin K, Tabata C, Sataka N, Nagai S, Moriyasu F, Kuno K. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C. Chest. 1994, 105:939-41. 10.1378\/chest.105.3.939","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.406","article-title":"Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS","volume":"124","author":"Abi-Nassif S","year":"2003","unstructured":"Abi-Nassif S, Mark EJ, Fogel RB, Hallisey RK Jr. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS. Chest. 2003, 124:406-10. 10.1378\/chest.124.1.406","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-0002-0000006464","article-title":"Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report","volume":"2","author":"Atug O","year":"2009","unstructured":"Atug O, Akin H, Alahdab YO, Ceyhan B, Tozun N, Ozdogan O. Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report. Cases J. 2009, 2:6464. 10.1186\/1757-1626-0002-0000006464","journal-title":"Cases J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80113-9","article-title":"Side effects of high-dose interferon therapy for chronic hepatitis C","volume":"25","author":"Okanoue T","year":"1996","unstructured":"Okanoue T, Sakamoto S, Itoh Y, et al.. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol. 1996, 25:283-291. 10.1016\/S0168-8278(96)80113-9","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80225-X","article-title":"Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study","volume":"25","author":"Dusheiko G","year":"1996","unstructured":"Dusheiko G, Main J, Thomas H, et al.. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol. 1996, 25:591-598. 10.1016\/S0168-8278(96)80225-X","journal-title":"J Hepatol"},{"key":"ref18","article-title":"The role of entecavir in the treatment of chronic hepatitis B","volume":"3","author":"Dimou E","year":"2007","unstructured":"Dimou E, Papadimitropoulos V, Hadziyannis SJ. The role of entecavir in the treatment of chronic hepatitis B. Ther Clin Risk Manag. 2007, 3:1077-86.","journal-title":"Ther Clin Risk Manag"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31348-1","article-title":"Pulmonary complications of treatment with pegylated interferon for hepatitis C infection: two case reports","volume":"12","author":"Hegade VS","year":"2013","unstructured":"Hegade VS, Sood R, Saralaya D, Moreea S. Pulmonary complications of treatment with pegylated interferon for hepatitis C infection: two case reports. Ann Hepatol. 2013, 12:461-465. 10.1016\/S1665-2681(19)31348-1","journal-title":"Ann Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/235633-excessive-dynamic-airway-collapse-after-entecavir-use-in-a-patient-with-pegylated-interferon-induced-undifferentiated-connective-tissue-disease-and-entecavir-use-to-prevent-hepatitis-b-virus-reactivation-upon-giving-rituximab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T13:18:00Z","timestamp":1718975880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/235633-excessive-dynamic-airway-collapse-after-entecavir-use-in-a-patient-with-pegylated-interferon-induced-undifferentiated-connective-tissue-disease-and-entecavir-use-to-prevent-hepatitis-b-virus-reactivation-upon-giving-rituximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.62835","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}